HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael W Sill Selected Research

Michael W Sill Research Topics

Disease

34Neoplasms (Cancer)
11/2020 - 08/2005
22Disease Progression
01/2020 - 09/2007
20Carcinoma (Carcinomatosis)
10/2020 - 08/2005
14Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 09/2008
14Endometrial Neoplasms (Endometrial Cancer)
12/2019 - 05/2007
8Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2020 - 03/2009
5Hypertension (High Blood Pressure)
02/2018 - 11/2007
5Pain (Aches)
07/2015 - 11/2007
5Ovarian Epithelial Carcinoma
03/2012 - 11/2007
4Neutropenia
01/2017 - 07/2008
4Carcinosarcoma
11/2012 - 05/2010
3Fistula
10/2017 - 03/2009
3Leiomyosarcoma
01/2017 - 09/2007
3Anemia
07/2015 - 03/2009
3Fatigue
07/2015 - 07/2009
3Vomiting
08/2012 - 09/2011
3Thrombocytopenia (Thrombopenia)
04/2012 - 02/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 03/2009
2Body Weight (Weight, Body)
10/2020 - 02/2014
2Diarrhea
01/2019 - 02/2011
2Abdominal Pain (Pain, Abdominal)
01/2019 - 04/2012
2Nausea
01/2019 - 04/2012
2Thromboembolism
10/2017 - 11/2007
2Dyspnea (Shortness of Breath)
07/2015 - 11/2007
2Febrile Neutropenia
04/2012 - 02/2011
1Hypoxia (Hypoxemia)
02/2018
1Wounds and Injuries (Trauma)
10/2017
1Hemorrhage
10/2017
1Uterine Cervical Dysplasia
01/2017
1Intestinal Fistula
01/2016
1Necrosis
01/2016
1Vascular Remodeling
09/2015
1Edema (Dropsy)
07/2015
1Neoplasm Metastasis (Metastasis)
12/2012
1Migraine Disorders (Migraine)
08/2012

Drug/Important Bio-Agent (IBA)

16Bevacizumab (Avastin)FDA Link
11/2020 - 11/2007
15Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 09/2008
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 11/2007
8Cisplatin (Platino)FDA LinkGeneric
10/2017 - 10/2009
7Carboplatin (JM8)FDA LinkGeneric
12/2012 - 09/2008
5Pharmaceutical PreparationsIBA
11/2020 - 07/2009
5Biomarkers (Surrogate Marker)IBA
02/2018 - 05/2007
5PlatinumIBA
06/2014 - 03/2011
4Topotecan (Hycamtin)FDA LinkGeneric
10/2017 - 03/2011
4ErbB Receptors (EGF Receptor)IBA
06/2013 - 08/2005
4Docetaxel (Taxotere)FDA Link
12/2012 - 12/2009
3Cetuximab (Erbitux)FDA Link
12/2012 - 05/2011
3Thalidomide (Thalomid)FDA Link
11/2012 - 05/2007
2fosbretabulin (combretastatin A4)IBA
10/2020 - 01/2016
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2019 - 07/2015
2Phosphotransferases (Kinase)IBA
01/2019 - 11/2018
2pazopanibFDA Link
02/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
10/2017 - 05/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2015 - 12/2009
2Tyrosine Kinase InhibitorsIBA
10/2014 - 11/2012
2Gefitinib (Iressa)FDA Link
06/2013 - 08/2005
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2013 - 11/2012
2Lapatinib (GW572016)FDA Link
11/2012 - 03/2012
2Imatinib Mesylate (Gleevec)FDA Link
05/2010 - 07/2008
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
05/2010 - 07/2008
2paclitaxel poliglumex (XYOTAX)IBA
12/2008 - 09/2008
1TubulinIBA
10/2020
1Angiogenesis InhibitorsIBA
10/2020
1IpilimumabIBA
01/2020
1NivolumabIBA
01/2020
1GSK2141795IBA
12/2019
1trametinibIBA
12/2019
1tyrosine receptor (receptor, tyrosine)IBA
01/2019
1cabozantinibIBA
01/2019
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2019
1EverolimusFDA Link
11/2018
1Interleukin-8 (Interleukin 8)IBA
02/2018
1CreatinineIBA
10/2017
1MLN 8237IBA
01/2017
1Celecoxib (Celebrex)FDA Link
01/2017
1Tromethamine (Trometamol)FDA Link
01/2016
1cediranib (AZD2171)IBA
09/2015
1trebananibIBA
09/2015
1Angiopoietin-1IBA
09/2015
1AZD 6244IBA
07/2015
1Mitogen-Activated Protein KinasesIBA
07/2015
1Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2015
1veliparibIBA
06/2015
1nintedanibIBA
12/2014
1brivanibIBA
10/2014
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2014
1CholesterolIBA
06/2014
1poly(ethylene glycol)-co-poly(ethyleneimine)IBA
06/2014
1Interleukin-12 (IL 12)IBA
06/2014
1Estrogen ReceptorsIBA
06/2013
1progesterone receptor AIBA
06/2013
1afliberceptIBA
12/2012
1Growth Factor ReceptorsIBA
12/2012
1iniparibIBA
09/2012

Therapy/Procedure

13Drug Therapy (Chemotherapy)
01/2020 - 05/2007
12Therapeutics
10/2020 - 09/2008
3Radiotherapy
02/2014 - 04/2012
1Hysterectomy
09/2015
1TP protocol
07/2015
1Combination Drug Therapy (Combination Chemotherapy)
02/2014